Aprocitentan mitigates doxorubicin-induced cardiotoxicity by inhibiting cuproptosis, oxidative stress, and mitochondrial impairments via the activation of sirtuin 7
For my pharma savvy folks, this is the Keytruda playbook
Sep 22 2018;7(10)doi:10.3390/jcm7100298 Singh RH, Lallan S
Aqua(Water), Centella Asiatica Leaf Water, Butylene Glycol, Propanediol, Niacinamide, 1,2-Hexanediol, Glycerin, Diethoxyethyl Succinate, Panthenol, Hydroxyacetophenone, Sodium Polyacryloyldimethyl Taurate, Styrene/Acrylates Copolymer, Allantoin, Glutathione, Cellulose Gum, Adenosine, Disodium EDTA, Citric Acid, Dipotassium Glycyrrhizate, Xanthan Gum, Inulin, Glyceryl Acrylate/Acrylic Acid Copolymer, Cellulose, Fructose, Glucose, Dipropylene Glycol, Squalane, C12-14 Alketh-12, Asiaticoside, Madecassic Acid, Asiatic Acid, Sodium Hyaluronate, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hippophae Rhamnoides Fruit Extract, Hydrolyzed Collagen, Beta-Glucan, Caprylyl Glycol, Nelumbium Speciosum Flower Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract Ingredients are subject to change at the manufacturer's discretion
12 weeks 2 x 10 mL bottles 3 vials use 9 mL
Not every patient achieves this outcome